FOXO1 and diabetic kidney disease: These results suggest that astragaloside IV may inhibit the PI3K/Akt signaling pathway to reduce the phosphorylation level of FoxO1, activate the activity of FoxO1, and initiate mitochondrial autophagy, thereby slowing down the development of DKD.